Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

(2021) Yunpeng Yang et al.   LANCET ONCOLOGY

Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017

(2020) Yujia Kong et al.   Cancer Medicine

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

(2020) Jing Huang et al.   LANCET ONCOLOGY

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

(2020) Jieqiong Liu et al.   Journal for ImmunoTherapy of Cancer

Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial

(2020) Benoit You et al.   JOURNAL OF CLINICAL ONCOLOGY

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

(2020) Chunyan Lan et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

(2020) John R. Lurain et al.   JOURNAL OF CLINICAL ONCOLOGY

Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial

(2020) Yun Fan et al.   Journal of Thoracic Oncology

PD ‐L1, B7‐H3 and VISTA are highly expressed in gestational trophoblastic neoplasia

(2019) Liju Zong et al.   HISTOPATHOLOGY

Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy

(2019) Angiolo Gadducci et al.   GYNECOLOGIC ONCOLOGY

When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients

(2019) Kirsty Balachandran et al.   GYNECOLOGIC ONCOLOGY

Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

(2019) Nadeem R. Abu-Rustum et al.   Journal of the National Comprehensive Cancer Network

Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

(2018) Jing Huang et al.   CLINICAL CANCER RESEARCH

Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study

(2018) Liju Zong et al.   Cancer Management and Research

Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study

(2018) Jianming Xu et al.   CLINICAL CANCER RESEARCH

Update on the diagnosis and management of gestational trophoblastic disease

(2018) Hextan Y.S. Ngan et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study

(2017) Yujia Kong et al.   GYNECOLOGIC ONCOLOGY

PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes

(2017) Pierre-Adrien Bolze et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia

(2017) Ehsan Ghorani et al.   LANCET

Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital

(2015) Changji Xiao et al.   BMC CANCER

Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy

(2012) Yi Li et al.   LEUKEMIA & LYMPHOMA

Prognosis of patients with relapsed and chemoresistant gestational trophoblastic neoplasia transferred to the Peking Union Medical College Hospital

(2009) F Feng et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY